WO2001062977A3 - Methods and composition for diagnosing and treating pseudoxanthoma elasticum and related conditions - Google Patents

Methods and composition for diagnosing and treating pseudoxanthoma elasticum and related conditions Download PDF

Info

Publication number
WO2001062977A3
WO2001062977A3 PCT/US2001/005741 US0105741W WO0162977A3 WO 2001062977 A3 WO2001062977 A3 WO 2001062977A3 US 0105741 W US0105741 W US 0105741W WO 0162977 A3 WO0162977 A3 WO 0162977A3
Authority
WO
WIPO (PCT)
Prior art keywords
methods
diagnosing
treating
composition
related conditions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2001/005741
Other languages
French (fr)
Other versions
WO2001062977A2 (en
Inventor
Charles D Boyd
Katalin Csiszar
Olivier Lesaux
Zsolt Urban
Sharon Terry
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Hawaiʻi at Mānoa
PXE International Inc
University of Hawai'i at Hilo
Original Assignee
University of Hawaiʻi at Mānoa
PXE International Inc
University of Hawai'i at Hilo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Hawaiʻi at Mānoa, PXE International Inc, University of Hawai'i at Hilo filed Critical University of Hawaiʻi at Mānoa
Priority to EP01914448A priority Critical patent/EP1259649B1/en
Priority to AT01914448T priority patent/ATE447622T1/en
Priority to AU2001239837A priority patent/AU2001239837B2/en
Priority to DE60140349T priority patent/DE60140349D1/en
Priority to CA2400954A priority patent/CA2400954C/en
Priority to AU3983701A priority patent/AU3983701A/en
Publication of WO2001062977A2 publication Critical patent/WO2001062977A2/en
Anticipated expiration legal-status Critical
Publication of WO2001062977A3 publication Critical patent/WO2001062977A3/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Dental Preparations (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Analysing Materials By The Use Of Radiation (AREA)

Abstract

Methods and compositions are provided for diagnosing and treating Pseudoxanthoma elasticum (PXE) patinet and PXE carriers. Methods and compositions are based on the discovery that PXE mutations are located in the MRP6 (ABCC6) gene.
PCT/US2001/005741 2000-02-23 2001-02-23 Methods and composition for diagnosing and treating pseudoxanthoma elasticum and related conditions Ceased WO2001062977A2 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
EP01914448A EP1259649B1 (en) 2000-02-23 2001-02-23 Methods and composition for diagnosing and treating pseudoxanthoma elasticum and related conditions
AT01914448T ATE447622T1 (en) 2000-02-23 2001-02-23 METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF PSEUDOXANTHOMA ELASTICUM AND SIMILAR CONDITIONS
AU2001239837A AU2001239837B2 (en) 2000-02-23 2001-02-23 Methods and composition for diagnosing and treating pseudoxanthoma elasticum and related conditions
DE60140349T DE60140349D1 (en) 2000-02-23 2001-02-23 METHODS AND COMPOSITIONS FOR DIAGNOSIS AND TREATMENT OF PSEUDOXANTHOMA ELASTICUM AND SIMILAR CONDITIONS
CA2400954A CA2400954C (en) 2000-02-23 2001-02-23 Methods and composition for diagnosing and treating pseudoxanthoma elasticum and related conditions
AU3983701A AU3983701A (en) 2000-02-23 2001-02-23 Methods and composition for diagnosing and treating pseudoxanthoma elasticum andrelated conditions

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18426900P 2000-02-23 2000-02-23
US60/184,269 2000-02-23

Publications (2)

Publication Number Publication Date
WO2001062977A2 WO2001062977A2 (en) 2001-08-30
WO2001062977A3 true WO2001062977A3 (en) 2002-10-03

Family

ID=22676233

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/005741 Ceased WO2001062977A2 (en) 2000-02-23 2001-02-23 Methods and composition for diagnosing and treating pseudoxanthoma elasticum and related conditions

Country Status (8)

Country Link
US (2) US6780587B2 (en)
EP (1) EP1259649B1 (en)
AT (1) ATE447622T1 (en)
AU (2) AU3983701A (en)
CA (1) CA2400954C (en)
DE (1) DE60140349D1 (en)
WO (1) WO2001062977A2 (en)
ZA (1) ZA200207641B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2015502917A (en) * 2011-10-28 2015-01-29 メルク・シャープ・アンド・ドーム・コーポレーションＭｅｒｃｋ Ｓｈａｒｐ ＆ Ｄｏｈｍｅ Ｃｏｒｐ． IL-19 as a biomarker for TSLP treatment
EP2773774A4 (en) 2011-11-03 2015-06-10 Merck Sharp & Dohme BIOMARKERS FOR THE TREATMENT OF TSLP
HK1245662A1 (en) 2014-12-19 2018-08-31 Alexion Pharmaceuticals, Inc. Methods of treating tissue calcification
US12134790B2 (en) 2017-09-27 2024-11-05 Inozyme Pharma, Inc. Methods of improving cardiovascular function and treating cardiovascular disease using a recombinant ectonucleotide pyrophosphatase phosphodiesterase (NPP1)
EP4162036A1 (en) 2020-06-09 2023-04-12 Inozyme Pharma, Inc. Soluble enpp1 or enpp3 proteins and uses thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998037764A1 (en) * 1997-02-27 1998-09-03 Baylor College Of Medicine Nucleic acid sequences for atp-binding cassette transporter

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998037764A1 (en) * 1997-02-27 1998-09-03 Baylor College Of Medicine Nucleic acid sequences for atp-binding cassette transporter

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
COTTON R G H: "CURRENT METHODS OF MUTATION DETECTION", MUTATION RESEARCH, AMSTERDAM, NL, vol. 285, 1993, pages 125 - 144, XP000443992, ISSN: 0027-5107 *
LE SAUX ET AL: "Mutations in a gene encoding an ABC transporter cause pseudoxanthoma elasticum", NATURE GENETICS, vol. 25, - June 2000 (2000-06-01), XP002201012 *
LE SAUX O ET AL: "Pseudoxanthoma Elasiticum maps to an 820-kb region of the p13.1 region of chromosome 16", GENOMICS, vol. 61, no. 1, 15 November 1999 (1999-11-15), pages 1 - 10, XP002201011 *
RINGPFEIL F ET AL: "Pseudoxanthoma elasticum: Mutations in the MRP6 gene encoding a transmembrane ATP-binding cassette (ABC) transporter", PROC. NATL. ACAD. SCI. USA, vol. 97, May 2000 (2000-05-01), pages 6001 - 6, XP002201013 *

Also Published As

Publication number Publication date
ZA200207641B (en) 2003-09-23
US20040166521A1 (en) 2004-08-26
EP1259649A2 (en) 2002-11-27
AU3983701A (en) 2001-09-03
AU2001239837B2 (en) 2006-06-22
EP1259649B1 (en) 2009-11-04
CA2400954C (en) 2010-04-20
US20030165828A1 (en) 2003-09-04
ATE447622T1 (en) 2009-11-15
WO2001062977A2 (en) 2001-08-30
US7364904B2 (en) 2008-04-29
CA2400954A1 (en) 2001-08-30
DE60140349D1 (en) 2009-12-17
US6780587B2 (en) 2004-08-24

Similar Documents

Publication Publication Date Title
WO2000028090A3 (en) Diagnostic assay for cancer
AU3227400A (en) Flow cell, analyte measurement apparatus and methods related thereto
AU2002230524A1 (en) Apparatus and methods for conducting assays and high throughput screening
AU2002243263A1 (en) Methods and reagents for identifying rare fetal cells in the material circulation
AU2001236491A1 (en) Oligonucleotide-tagged semiconductor nanocrystals for microarray and fluorescence in situ hybridization
AU2003298048A1 (en) Hydrodynamic static mixing apparatus and method for use thereof in transporting, conditioning and separating oil sands and the like
WO2001075178A3 (en) Methods for identifying peptide aptamers capable of altering a cell phenotype
AU6907000A (en) Radiation-polymerizable composition, flushing and grinding vehicle containing same
AU3655499A (en) Repeat polymorphism in the frataxin gene and uses therefor
CA2438574A1 (en) Method of detecting nucleotide polymorphism
WO2006038208A3 (en) Agents capable of downregulating an msf-a - dependent hif-1α and use thereof in cancer treatment
AU6813000A (en) Composition comprising micronutrients in combination with prebiotics, probiotics, and/or synbiotics
AU2001225804A1 (en) Improved test structures and methods for inspecting and utilizing the same
WO2002047535A3 (en) High throughput assay to detect inhibitors of the map kinase pathway
AU2002305117A1 (en) Improved apparatus, methods and compositions for biotechnical separations
AU5781800A (en) Methods and compositions for assaying analytes
AU2001285219A1 (en) Methods and compositions for identifying nucleic acid molecules using nucleolytic activities and hybridization
AU2002952797A0 (en) Centrifugal device and method using same
WO1999050459A3 (en) High throughput in vitro screening assays for transcription modulators
AU5667499A (en) Apparatus and methods for identifying quenching effects in luminescence assays
WO2005054495A3 (en) Ligand-containing micelles and uses thereof
WO2005028621A3 (en) Assays with primary cells
ZA200207641B (en) Methods and composition for diagnosing and treating pseudoxanthoma elasticum and related conditions.
AU2002304163A1 (en) Polypeptide unstabilizing protein in cells under aerobic conditions and DNA encoding the same
WO2004083241A3 (en) Btc-interacting proteins and use thereof

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2400954

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2001239837

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2001914448

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2002/07641

Country of ref document: ZA

Ref document number: 200207641

Country of ref document: ZA

AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

WWP Wipo information: published in national office

Ref document number: 2001914448

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

NENP Non-entry into the national phase

Ref country code: JP